serine/threonine Kinase 17a (STK17A) (N-Term) Peptide
STK17A
Reactivité: Humain
BP
Sodium azide
-
- Antigène Tous les produits STK17A
- STK17A (serine/threonine Kinase 17a (STK17A))
- Protein Region
- N-Term
- Origine
- Humain
- Application
- Blocking Peptide (BP)
- Attributs du produit
-
15 amino amino terminus of human DRAK1.
Human
-
-
- Indications d'application
- DRAK1 peptide is used for blocking the activity of DRAK1.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Date de péremption
- 12 months
-
- Antigène
- STK17A (serine/threonine Kinase 17a (STK17A))
- Synonymes
- STK17A Peptide, DRAK1 Peptide, RDRAK1 Peptide, serine/threonine kinase 17a Peptide, serine/threonine kinase 17a L homeolog Peptide, STK17A Peptide, stk17a Peptide, stk17a.L Peptide
-
Vous êtes ici:
